US Patent Issued to Medtronic Ireland Manufacturing UnLtd. on Nov. 3 for "Modulation of targeted nerve fibers" (California, Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,778,673, issued on Nov. 3, was assigned to Medtronic Ireland Manufacturing UnLtd. Co. (Dublin).

"Modulation of targeted nerve fibers" was invented by Bobak Robert Azamian (Newport Coast, Calif.), Jonathan Allen Coe (Menlo Park, Calif.) and Scott Bradley Vafai (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen...